Skip directly to Accessibility Notice

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH

  • Exchange

    NASDAQ

  • ETF Structure

    Physical

  • Administrator

    Van Eck Associates

  • Custodian

    State Street Bank and Trust Company

  • Index Ticker

    MVPPHTR

  • Index Rebalancing

    Quarterly

 
as of 01/15/21

  • 30-Day SEC Yield1

    1.48%

  • Total Net Assets

    $253.6M

  • Number of Holdings

    25

  • Options

    Available

  • Gross Expense Ratio2

    0.42%

  • Net Expense Ratio/TER2

    0.36%

  • Distribution Frequency

    Quarterly
Schedule a Call
How to Buy

Key Points

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

  • Fund Ticker

    PPH

  • Index Total Return Ticker

    MVPPHTR

  • NAV

    PPHNV

  • Intraday NAV (IIV)4

    PPHIV

  • Shares Outstanding

    3,638,138

  • Estimated Cash

    PPHEU

  • Total Cash

    PPHTC

  • CUSIP

    92189F692

  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%

  • Other Expenses

    0.07%

  • Gross Expense Ratio

    0.42%

  • Fee Waivers and
    Expense Reimbursement

    -0.06%

  • Net Expense Ratio/TER2

    0.36%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2021. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Prices as of 01/15/21

NAV/
Market Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change
NAV/
Last Price 		Premium/
Discount 		Prem/Discount
Distribution Charts 		NAV &
Prem/Discount
History 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $69.71
$69.72		 48,999
34,570		 $0.29 / +0.42%
$0.34 / +0.49%		 +5.33%
+5.29%
 $0.01
0.02%		 0.05%

Premium/Discount History as of 01/15/21

Calendar Year 2019 1Q 2020 2Q 2020 3Q 2020 4Q 2020 Premium/Discount Charts NAV & Prem/Discount History
Days closed at a premium 88 22 32 29 41
PPH Days closed at NAV 22 5 3 8 1
Days closed at a discount 142 35 28 27 22

Performance History: Average Annual Total Returns* (%)
View All ETFs View All Indices

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 2.15 7.47 5.20 5.20 5.74 2.33 -- 9.26
PPH (Share Price) 2.20 7.35 5.33 5.33 5.77 2.32 -- 9.38
MVPPHTR (Index) 2.49 7.80 4.96 4.96 5.60 2.26 -- 9.22
Performance Differential (NAV - Index) -0.34 -0.33 0.24 0.24 0.14 0.07 -- 0.04
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 2.15 7.47 5.20 5.20 5.74 2.33 -- 9.26
PPH (Share Price) 2.20 7.35 5.33 5.33 5.77 2.32 -- 9.38
MVPPHTR (Index) 2.49 7.80 4.96 4.96 5.60 2.26 -- 9.22
Performance Differential (NAV - Index) -0.34 -0.33 0.24 0.24 0.14 0.07 -- 0.04

*Returns less than one year are not annualized.

The table presents past performance which is no guarantee of future results and which may be lower or higher than current performance. Returns reflect temporary contractual fee waivers and/or expense reimbursements. Had the ETF incurred all expenses and fees, investment returns would have been reduced. Investment returns and ETF share values will fluctuate so that investors' shares, when redeemed, may be worth more or less than their original cost. ETF returns assume that dividends and capital gains distributions have been reinvested in the Fund at NAV.

Top 10 Holdings (%) as of 12/31/20 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$) 		% of Net
Assets
ELI LILLY AND CO
LLY US
79,707
13,457,730 5.35
NOVARTIS AG
NVS US
137,473
12,981,575 5.16
JOHNSON & JOHNSON
JNJ US
82,262
12,946,394 5.14
BRISTOL-MYERS SQUIBB CO
BMY US
206,730
12,823,462 5.09
CATALENT INC
CTLT US
122,789
12,778,651 5.08
NOVO NORDISK A/S
NVO US
179,276
12,522,429 4.98
ABBVIE INC
ABBV US
115,892
12,417,828 4.93
MERCK & CO INC
MRK US
150,882
12,342,148 4.90
SANOFI
SNY US
253,861
12,335,106 4.90
VIATRIS INC
VTRS US
646,953
12,123,899 4.82
Top 10 Total (%) 50.35
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 12/31/20

  • Country

    % of Net Assets
  • ■

    United States

    65.63
  • ■

    United Kingdom

    9.98
  • ■

    Switzerland

    5.16
  • ■

    Denmark

    4.98
  • ■

    France

    4.90
  • ■

    Japan

    4.39
  • ■

    Israel

    4.08
  • ■

    Ireland

    0.93
  • ■

    Other/Cash

    -0.04

Sector Weightings (%) as of 12/31/20

  • Sector

    % of Net Assets
  • ■

    Health Care

    100.0
  • ■

    Other/Cash

    0.0